Skye Bioscience, Inc. (SKYE) Free cash flow 2016–2025
Skye Bioscience, Inc. (SKYE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$43.1MFY2025 · since FY2016: -$3.6M → -$43.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.1M | -60.5% |
| FY2024 | -$26.8M | -92.2% |
| FY2023 | -$14.0M | -9.3% |
| FY2022 | -$12.8M | -94.5% |
| FY2021 | -$6.6M | -8.3% |
| FY2020 | -$6.1M | — |
| FY2018 | -$3.9M | -17.8% |
| FY2017 | -$3.4M | +6.0% |
| FY2016 | -$3.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice